<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC5502740/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502740/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Pharmacogenetics and genomics"><meta name="citation_title" content="Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults"><meta name="citation_authors" content="Quinn S. Wells, Olivia J. Veatch, Joshua P. Fessel, Aron Y. Joon, Rebecca T. Levinson, Jonathan D. Mosley, Elizabeth P. Held, Chase S. Lindsay, Christian M. Shaffer, Peter E. Weeke, Andrew M. Glazer, Kevin R. Bersell, Sara L. Van Driest, Jason H. Karnes, Marcia A. Blair, Lore W. Lagrone, Yan R. Su, Erica A. Bowton, Ziding Feng, Bonnie Ky, Daniel J. Lenihan, Michael J. Fisch, Joshua C. Denny, Dan M. Roden"><meta name="citation_date" content="July 2017"><meta name="citation_issue" content="7"><meta name="citation_volume" content="27"><meta name="citation_firstpage" content="247"><meta name="citation_doi" content="10.1097/FPC.0000000000000284"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5502740/?report=abstract"><meta name="citation_pmid" content="28542097"><meta name="DC.Title" content="Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Quinn S. Wells"><meta name="DC.Contributor" content="Olivia J. Veatch"><meta name="DC.Contributor" content="Joshua P. Fessel"><meta name="DC.Contributor" content="Aron Y. Joon"><meta name="DC.Contributor" content="Rebecca T. Levinson"><meta name="DC.Contributor" content="Jonathan D. Mosley"><meta name="DC.Contributor" content="Elizabeth P. Held"><meta name="DC.Contributor" content="Chase S. Lindsay"><meta name="DC.Contributor" content="Christian M. Shaffer"><meta name="DC.Contributor" content="Peter E. Weeke"><meta name="DC.Contributor" content="Andrew M. Glazer"><meta name="DC.Contributor" content="Kevin R. Bersell"><meta name="DC.Contributor" content="Sara L. Van Driest"><meta name="DC.Contributor" content="Jason H. Karnes"><meta name="DC.Contributor" content="Marcia A. Blair"><meta name="DC.Contributor" content="Lore W. Lagrone"><meta name="DC.Contributor" content="Yan R. Su"><meta name="DC.Contributor" content="Erica A. Bowton"><meta name="DC.Contributor" content="Ziding Feng"><meta name="DC.Contributor" content="Bonnie Ky"><meta name="DC.Contributor" content="Daniel J. Lenihan"><meta name="DC.Contributor" content="Michael J. Fisch"><meta name="DC.Contributor" content="Joshua C. Denny"><meta name="DC.Contributor" content="Dan M. Roden"><meta name="DC.Date" content="2017 Jul"><meta name="DC.Identifier" content="10.1097/FPC.0000000000000284"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults"><meta property="og:type" content="article"><meta property="og:description" content="Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity. Candidate gene and genome-wide studies have identified putative risk loci for overt cardiotoxicity and heart failure, but there has been no comprehensive ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502740/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC5502740/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC5502740/pdf/nihms870773.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8A1441DD5A2FB10000000006B403E5.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502740%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="protein" class="last">Protein</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC5502740</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Pharmacogenet Genomics</a></span>. Author manuscript; available in PMC 2018 Jul 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=28542097" target="pmc_ext" ref="reftype=publisher&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Pharmacogenet Genomics. 2017 Jul; 27(7): 247–254. </span></a></div> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1097%2FFPC.0000000000000284" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1097/FPC.0000000000000284</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5502740</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS870773</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/28542097">28542097</a></div></div></div></div><h1 class="content-title">Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Wells%20QS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527605964560" co-class="co-affbox">Quinn S. Wells</a>, MD, PharmD, MSc,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Veatch%20OJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527613148400" co-class="co-affbox">Olivia J. Veatch</a>, PhD,<sup>‡</sup> <a href="/pubmed/?term=Fessel%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527616128336" co-class="co-affbox">Joshua P. Fessel</a>, MD, PhD,<sup>*</sup> <a href="/pubmed/?term=Joon%20AY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527604072784" co-class="co-affbox">Aron Y. Joon</a>, MS,<sup>||</sup> <a href="/pubmed/?term=Levinson%20RT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527604070544" co-class="co-affbox">Rebecca T. Levinson</a>, PhD,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Mosley%20JD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527602227056" co-class="co-affbox">Jonathan D. Mosley</a>, MD, PhD,<sup>*</sup> <a href="/pubmed/?term=Held%20EP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527601664608" co-class="co-affbox">Elizabeth P. Held</a>, MD,<sup>*</sup> <a href="/pubmed/?term=Lindsay%20CS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527601786192" co-class="co-affbox">Chase S. Lindsay</a>, BS,<sup>*</sup> <a href="/pubmed/?term=Shaffer%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527614248800" co-class="co-affbox">Christian M. Shaffer</a>, BS,<sup>*</sup> <a href="/pubmed/?term=Weeke%20PE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527612257568" co-class="co-affbox">Peter E. Weeke</a>, MD,<sup>*</sup><sup>‡‡</sup> <a href="/pubmed/?term=Glazer%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527615031024" co-class="co-affbox">Andrew M. Glazer</a>, PhD,<sup>*</sup> <a href="/pubmed/?term=Bersell%20KR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527615028784" co-class="co-affbox">Kevin R. Bersell</a>, PhD,<sup>*</sup> <a href="/pubmed/?term=Van%20Driest%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527602390976" co-class="co-affbox">Sara L. Van Driest</a>, MD, PhD,<sup>*</sup><sup>§</sup> <a href="/pubmed/?term=Karnes%20JH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527605315056" co-class="co-affbox">Jason H. Karnes</a>, PharmD,<sup>*</sup> <a href="/pubmed/?term=Blair%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527615033280" co-class="co-affbox">Marcia A. Blair</a>, MS,<sup>*</sup> <a href="/pubmed/?term=Lagrone%20LW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527607142576" co-class="co-affbox">Lore W. Lagrone</a>,<sup>#</sup> <a href="/pubmed/?term=Su%20YR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527605793664" co-class="co-affbox">Yan R. Su</a>, MD, PhD,<sup>*</sup> <a href="/pubmed/?term=Bowton%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527605791424" co-class="co-affbox">Erica A. Bowton</a>, PhD,<sup>**</sup> <a href="/pubmed/?term=Feng%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527602482256" co-class="co-affbox">Ziding Feng</a>, PhD,<sup>||</sup> <a href="/pubmed/?term=Ky%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527613579520" co-class="co-affbox">Bonnie Ky</a>, MD,<sup>††</sup> <a href="/pubmed/?term=Lenihan%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527611892672" co-class="co-affbox">Daniel J. Lenihan</a>, MD,<sup>*</sup> <a href="/pubmed/?term=Fisch%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527611890432" co-class="co-affbox">Michael J. Fisch</a>, MD,<sup>#</sup> <a href="/pubmed/?term=Denny%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527610097392" co-class="co-affbox">Joshua C. Denny</a>, MD,<sup>*</sup><sup>‡‡</sup> and  <a href="/pubmed/?term=Roden%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097" class="affpopup" co-rid="_co_idm140527609580880" co-class="co-affbox">Dan M. Roden</a>, MD<sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140527605964560"><h3 class="no_margin">Quinn S. Wells</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><p>  <sup>†</sup>Vanderbilt Translational and Clinical Cardiovascular (VTRACC) research group, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Wells%20QS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Quinn S. Wells</a></div></div><div id="_co_idm140527613148400"><h3 class="no_margin">Olivia J. Veatch</h3><p>  <sup>‡</sup>Department of Neurology, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Veatch%20OJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Olivia J. Veatch</a></div></div><div id="_co_idm140527616128336"><h3 class="no_margin">Joshua P. Fessel</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Fessel%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Joshua P. Fessel</a></div></div><div id="_co_idm140527604072784"><h3 class="no_margin">Aron Y. Joon</h3><p>  <sup>||</sup>Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX</p><div>Find articles by <a href="/pubmed/?term=Joon%20AY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Aron Y. Joon</a></div></div><div id="_co_idm140527604070544"><h3 class="no_margin">Rebecca T. Levinson</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><p>  <sup>†</sup>Vanderbilt Translational and Clinical Cardiovascular (VTRACC) research group, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Levinson%20RT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Rebecca T. Levinson</a></div></div><div id="_co_idm140527602227056"><h3 class="no_margin">Jonathan D. Mosley</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Mosley%20JD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Jonathan D. Mosley</a></div></div><div id="_co_idm140527601664608"><h3 class="no_margin">Elizabeth P. Held</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Held%20EP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Elizabeth P. Held</a></div></div><div id="_co_idm140527601786192"><h3 class="no_margin">Chase S. Lindsay</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Lindsay%20CS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Chase S. Lindsay</a></div></div><div id="_co_idm140527614248800"><h3 class="no_margin">Christian M. Shaffer</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Shaffer%20CM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Christian M. Shaffer</a></div></div><div id="_co_idm140527612257568"><h3 class="no_margin">Peter E. Weeke</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><p>  <sup>‡‡</sup>Department of Biomedical Informatics, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Weeke%20PE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Peter E. Weeke</a></div></div><div id="_co_idm140527615031024"><h3 class="no_margin">Andrew M. Glazer</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Glazer%20AM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Andrew M. Glazer</a></div></div><div id="_co_idm140527615028784"><h3 class="no_margin">Kevin R. Bersell</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Bersell%20KR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Kevin R. Bersell</a></div></div><div id="_co_idm140527602390976"><h3 class="no_margin">Sara L. Van Driest</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><p>  <sup>§</sup>Department of Pediatrics, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Van%20Driest%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Sara L. Van Driest</a></div></div><div id="_co_idm140527605315056"><h3 class="no_margin">Jason H. Karnes</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Karnes%20JH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Jason H. Karnes</a></div></div><div id="_co_idm140527615033280"><h3 class="no_margin">Marcia A. Blair</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Blair%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Marcia A. Blair</a></div></div><div id="_co_idm140527607142576"><h3 class="no_margin">Lore W. Lagrone</h3><p>  <sup>#</sup>Department of General Oncology, University of Texas MD Anderson Cancer Center, Houston, TX</p><div>Find articles by <a href="/pubmed/?term=Lagrone%20LW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Lore W. Lagrone</a></div></div><div id="_co_idm140527605793664"><h3 class="no_margin">Yan R. Su</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Su%20YR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Yan R. Su</a></div></div><div id="_co_idm140527605791424"><h3 class="no_margin">Erica A. Bowton</h3><p>  <sup>**</sup>Institute for Clinical and Translational Research, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Bowton%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Erica A. Bowton</a></div></div><div id="_co_idm140527602482256"><h3 class="no_margin">Ziding Feng</h3><p>  <sup>||</sup>Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX</p><div>Find articles by <a href="/pubmed/?term=Feng%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Ziding Feng</a></div></div><div id="_co_idm140527613579520"><h3 class="no_margin">Bonnie Ky</h3><p>  <sup>††</sup>Department of Medicine, University of Pennsylvania, Philadelphia, PA</p><div>Find articles by <a href="/pubmed/?term=Ky%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Bonnie Ky</a></div></div><div id="_co_idm140527611892672"><h3 class="no_margin">Daniel J. Lenihan</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Lenihan%20DJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Daniel J. Lenihan</a></div></div><div id="_co_idm140527611890432"><h3 class="no_margin">Michael J. Fisch</h3><p>  <sup>#</sup>Department of General Oncology, University of Texas MD Anderson Cancer Center, Houston, TX</p><div>Find articles by <a href="/pubmed/?term=Fisch%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Michael J. Fisch</a></div></div><div id="_co_idm140527610097392"><h3 class="no_margin">Joshua C. Denny</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><p>  <sup>‡‡</sup>Department of Biomedical Informatics, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Denny%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Joshua C. Denny</a></div></div><div id="_co_idm140527609580880"><h3 class="no_margin">Dan M. Roden</h3><p>  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</p><div>Find articles by <a href="/pubmed/?term=Roden%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28542097">Dan M. Roden</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140527611154832_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140527611154832_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140527611154832_ai" style="display:none"><div class="fm-affl" id="A1" lang="en">  <sup>*</sup>Department of Medicine, Vanderbilt University, Nashville, TN</div><div class="fm-affl" id="A2" lang="en">  <sup>†</sup>Vanderbilt Translational and Clinical Cardiovascular (VTRACC) research group, Vanderbilt University, Nashville, TN</div><div class="fm-affl" id="A3" lang="en">  <sup>‡</sup>Department of Neurology, Vanderbilt University, Nashville, TN</div><div class="fm-affl" id="A4" lang="en">  <sup>§</sup>Department of Pediatrics, Vanderbilt University, Nashville, TN</div><div class="fm-affl" id="A5" lang="en">  <sup>**</sup>Institute for Clinical and Translational Research, Vanderbilt University, Nashville, TN</div><div class="fm-affl" id="A6" lang="en">  <sup>‡‡</sup>Department of Biomedical Informatics, Vanderbilt University, Nashville, TN</div><div class="fm-affl" id="A7" lang="en">  <sup>#</sup>Department of General Oncology, University of Texas MD Anderson Cancer Center, Houston, TX</div><div class="fm-affl" id="A8" lang="en">  <sup>||</sup>Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX</div><div class="fm-affl" id="A9" lang="en">  <sup>††</sup>Department of Medicine, University of Pennsylvania, Philadelphia, PA</div><div class="fm-affl" id="A10" lang="en">  <sup>‡‡</sup>Department of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Denmark</div><div id="FN1">Correspondence: Quinn Wells, 2525 West End Avenue, Suite 300, Nashville, Tennessee 37203, Phone: (615) 936-1819, Fax: (615) 322-3837, <a href="mailto:dev@null" data-email="ude.tlibrednav@sllew.s.nniuq" class="oemail">ude.tlibrednav@sllew.s.nniuq</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140527611154832_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=28542097" target="pmc_ext" ref="reftype=publisher&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Pharmacogenet Genomics</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC5502740/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="8" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_1.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_1.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_1.docx</a><span style="color:gray"> (54K)</span></div><div class="small guid">GUID:&nbsp;90CC0672-7CA9-4A50-B9BC-990AC2A8BE4B</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_2.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_2.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_2.docx</a><span style="color:gray"> (2.2M)</span></div><div class="small guid">GUID:&nbsp;8EB08152-B712-4542-9A7C-24E22E4E9318</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_3.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_3.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_3.docx</a><span style="color:gray"> (1.7M)</span></div><div class="small guid">GUID:&nbsp;636F7992-D95F-4077-87D4-7D98C62C9E78</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_4.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_4.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_4.docx</a><span style="color:gray"> (88K)</span></div><div class="small guid">GUID:&nbsp;5E702A95-23BB-4AC8-A636-94F402D9D3F1</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_5.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_5.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_5.docx</a><span style="color:gray"> (76K)</span></div><div class="small guid">GUID:&nbsp;5FE97BAF-F905-49F8-8556-F6EE5032D425</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_6.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_6.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_6.docx</a><span style="color:gray"> (1.8M)</span></div><div class="small guid">GUID:&nbsp;E11B66CD-FF04-4BA1-A12A-3C8B689DFE38</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_7.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_7.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_7.docx</a><span style="color:gray"> (1.8M)</span></div><div class="small guid">GUID:&nbsp;1AE1B31C-B985-41EF-B167-56495A1FA7D2</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplemental Digital Content_8.</strong></div><div><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_8.docx" data-ga-action="click_feat_suppl">NIHMS870773-supplement-Supplemental_Digital_Content_8.docx</a><span style="color:gray"> (97K)</span></div><div class="small guid">GUID:&nbsp;0E9678EF-D3C6-4E15-A160-9CA44BE03C78</div></div></dd></dl></div><div id="idm140527612853152" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140527612853152title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Background</h3><p id="P1" class="p p-first-last">Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity. Candidate gene and genome-wide studies have identified putative risk loci for overt cardiotoxicity and heart failure, but there has been no comprehensive assessment of genomic variation influencing the intermediate phenotype of anthracycline-related changes in left ventricular (LV) function. The purpose of this study was to identify genetic factors influencing changes in LV function after anthracycline chemotherapy.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">We conducted a genome-wide association study (GWAS) of change in LV function after anthracycline exposure in 385 subjects identified from BioVU, a resource linking DNA samples to de-identified electronic medical record data. Variants with p-values &lt;1×10<sup>−5</sup> were independently tested for replication in a cohort of 181 anthracycline-exposed subjects from a prospective clinical trial. Pathway analysis was performed to assess combined effects of multiple genetic variants.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">Both cohorts were middle-aged adults of predominantly European descent. Among 11 candidate loci identified in discovery GWAS, one single nucleotide polymorphism (SNP) near PR Domain Containing 2, With ZNF Domain (<em>PRDM2</em>), rs7542939, had a combined p-value of 6.5×10<sup>−7</sup> in meta-analysis. Eighteen Kyoto Encyclopedia of Gene and Genomes (KEGG) pathways showed strong enrichment for variants associated with the primary outcome. Identified pathways related to DNA repair, cellular metabolism, and cardiac remodeling.</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions</h3><p id="P4" class="p p-first-last">Using genome-wide association we identified a novel candidate susceptibility locus near <em>PRDM2</em>. Variation in genes belonging to pathways related to DNA repair, metabolism, and cardiac remodeling may influence changes in LV function after anthracycline exposure.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Anthracycline, cardiotoxicity, genome-wide association study, pathway analysis</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">INTRODUCTION</h2><p id="P5" class="p p-first">Anthracyclines are important chemotherapeutic agents, but their use is limited by cardiotoxicity that characteristically manifests as progressive systolic dysfunction.<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203465">1</a></sup> Many mechanisms for cardiotoxicity have been proposed, including production of reactive oxygen species<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203433">2</a></sup> and alterations in anthracycline metabolism and transport.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203454">3</a>,<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203444">4</a></sup> More recent data suggest anthracycline-mediated inhibition of topoisomerases, in particular, topoisomerase IIβ and mitochondrial topoisomerase I, are central to cardiotoxicity, producing double strand DNA breaks, activation of apoptotic pathways, and ultimately impaired mitochondrial function and decreased mitochondrial biogenesis.<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203439">5</a>,<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203445">6</a></sup> Anthracyclines also impair sarcomere maintenance, disrupt cell survival signaling, and impair cellular fatty acid metabolism.<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203447">2</a>,<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203424">7</a></sup></p><p id="P6">Anthracycline cardiotoxicity is dose-dependent at a population level, but substantial inter-individual variability makes it difficult to predict which patients will be affected even when cumulative exposure and clinical parameters are known, indicating influences beyond dose and known risk factors play a substantial role in susceptibility. Several genetic variants influencing development of overt cardiotoxicity and heart failure have been implicated by candidate gene analyses and genome wide association studies (GWAS), primarily in childhood cancers.<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203451">8</a>–<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203456">13</a></sup> Nevertheless, known genetic factors do not explain all the observed variability in susceptibility.</p><p id="P7" class="p p-last">Common definitions of anthracycline-induced cardiotoxicity require a significant decrease in cardiac function or clinical evidence of cardiac insufficiency.<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203422">11</a>,<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203446">13</a></sup> However, dichotomous classifications have limitations, as more subtle effects may be meaningful, and even severe cardiac dysfunction can be asymptomatic. Indeed, continuous measures of left ventricular (LV) structure and function in the general population are both heritable and associated with important cardiovascular outcomes.<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203431">14</a></sup> The quantitative change in LV function is an intermediate phenotype of anthracycline-induced cardiotoxicity, and, importantly, early reductions in this metric are associated with later development of overt cardiotoxicity.<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203459">15</a></sup> However, the genomic influences on anthracycline-induced alterations in cardiac function, particularly in adults, have not been studied in a genome-wide, unbiased fashion. Understanding the genomics of this intermediate phenotype may help characterize quantitative, mechanistic aspects of cardiotoxicity and form the basis for identification of at-risk individuals and implementation of measures to minimize or prevent toxicity.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">METHODS</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Study Populations</h3><div id="S8" class="sec sec-first"><p></p><h4 id="S8title" class="inline">Discovery GWAS </h4><p id="P8" class="p p-first">The discovery dataset was generated from BioVU, a Vanderbilt resource linking DNA samples to de-identified electronic medical records (EMR). The development, implementation, and use of BioVU as a platform for discovery has been previously described.<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203452">16</a>,<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203436">17</a></sup> Briefly, BioVU contains over 215,000 DNA samples extracted from blood leftover after routine clinical care at Vanderbilt University Medical Center.</p><p id="P9" class="p p-last">Subjects with anthracycline exposure were identified using key word searches and automated queries of procedure codes (see <a href="#SD1" rid="SD1" class=" supplementary-material">Text, Supplemental Digital Content 1</a>). Assessments of left ventricular ejection fraction (LVEF) were extracted retrospectively from clinical reports of imaging modalities including transthoracic echocardiography, radionuclide ventriculography, single-photon emission computed tomography, cardiac computed tomography, and cardiac magnetic resonance imaging. Imaging was performed at the discretion of providers as clinically indicated. Cumulative anthracycline dose, pre- and post-chemotherapy LVEF values, and pre-chemotherapy clinical covariates were extracted by manual review of the EMR. Subjects were excluded if they were not exposed to anthracycline, had no measures of LVEF after chemotherapy initiation, or had insufficient EMR documentation of covariates. LVEF measurements acquired during acute illness (e.g., sepsis) were excluded. Anthracycline exposures considered were doxorubicin, doxorubicin liposomal, daunorubicin, idarubicin, and epirubicin. Doses were converted to doxorubicin equivalents (see <a href="#SD1" rid="SD1" class=" supplementary-material">Text, Supplemental Digital Content 1</a>)<sup><a href="#R18" rid="R18" class=" bibr popnode">18</a></sup>, indexed to body surface area, and expressed as doxorubicin equivalents mg/m<sup>2</sup>. In a minority of cases, baseline LVEF and cumulative anthracycline dose were not documented in subjects with otherwise complete information. These data were imputed using multiple imputation implemented in SPSS statistical software version 20 (IBM Corp., Armonk, NY).</p></div><div id="S9" class="sec sec-last"><p></p><h4 id="S9title" class="inline">Replication </h4><p id="P10" class="p p-first-last">The replication dataset was drawn from subjects enrolled in the “Patients undergoing anthracycline-based chemotherapy to assess the effectiveness of using biomarkers to detect and identify cardiotoxicity and describe treatment” (PREDICT) study (<em>ClinicalTrials.gov number</em> NCT01311843). PREDICT is a multicenter study with coordinating sites at MD Anderson Cancer Center, Houston, TX and Vanderbilt University Medical Center, Nashville, TN. The study protocol was approved by the Institutional Review Boards of both institutions. At enrollment, subjects were age ≥18 years, had an LVEF ≥50%, and were starting a new course of chemotherapy that included an anthracycline. Prior chemotherapy exposure, including anthracyclines, was not an exclusion criteria. Subjects underwent serial assessment of cardiac function with transthoracic echocardiography at baseline, 6 and 12 months after initiation of chemotherapy, or if indicated clinically. To ensure no subjects were included in both discovery and replication populations, only subjects from outside Vanderbilt were considered for inclusion.</p></div></div><div id="S10" class="sec"><h3 id="S10title">Genotyping and Imputation</h3><p id="P11" class="p p-first-last">BioVU subjects were genotyped in the Vanderbilt Technologies for Advanced Genomics (VANTAGE) Core using the Illumina Omni 1-Quad platform. Pre-imputation quality control filters were applied at the sample level (exclusion criteria: call rate &lt;98%, sex discrepancy, relatedness, duplicate discordance, and HapMap discordance) and single nucleotide polymorphism (SNP) level (exclusion criteria: call rate &lt;98%, replicate discordance, and Mendelian errors). Genotypes were imputed to 1000 Genomes Phase 1 version 3 (April 19, 2012) using IMPUTE2 software<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203463">19</a></sup> and reference panels from all 1000 Genomes populations, and alleles with confidence &gt;0.9 were retained (see <a href="#SD1" rid="SD1" class=" supplementary-material">Text, Supplemental Digital Content 1</a>). Candidate SNPs with p-values &lt;1×10<sup>−5</sup> in discovery were genotyped in the replication cohort using the Sequenom MassArray genotyping system. Quality control parameters included sample genotyping efficiency &gt;90% and SNP genotyping efficiency &gt;95%.</p></div><div id="S11" class="sec"><h3 id="S11title">Statistical Analysis</h3><p id="P12" class="p p-first">The primary outcome was maximal change in LVEF from pre-chemotherapy measurement. This intermediate phenotype was chosen because changes in this parameter are used in clinical practice to define and detect anthracycline cardiotoxicity. If LVEF increased from baseline, the maximum positive change and cumulative chemotherapy dose up to that time point was recorded. If LVEF decreased from baseline the maximum negative change and cumulative chemotherapy to that time point was recorded. If both positive and negative changes from baseline LVEF were present, the maximum negative change and cumulative chemotherapy to that time point were recorded.</p><p id="P13" class="p p-last">In discovery GWAS, multiple linear regression, implemented in PLINK, was used to test for association between SNPs and change in LVEF adjusting for age, gender, baseline LVEF, cumulative anthracycline dose at time of outcome LVEF, follow-up time from start of anthracycline, number of cardiac risk factors (hypertension, diabetes, coronary artery disease, dyslipidemia, smoking), and concomitant trastuzumab. All subjects were included regardless of ancestry, and principal components one and two (which explained 28% of the variance in the genetic data) were included to adjust for possible population stratification (see <a href="#SD3" rid="SD3" class=" supplementary-material">Figures, Supplemental Digital Content 3</a> and <a href="#SD4" rid="SD4" class=" supplementary-material">4</a>). Only SNPs with minor allele frequency (MAF) ≥ 0.05 were included in analyses. <em>A priori</em> genome-wide significance was defined as 5×10<sup>−8</sup>. Lead SNPs from loci with p-values &lt;1×10<sup>−5</sup> in the discovery GWAS were tested for association in the replication cohort. Analysis again utilized multiple linear regression with clinical covariates as in discovery, with the exception of the substitution of self-reported ancestry for principal components. Analysis was conducted using the R statistical package. The combined p-value from the discovery GWAS and replication for each SNP was determined using inverse variance based meta-analysis (see <a href="#SD1" rid="SD1" class=" supplementary-material">Text, Supplemental Digital Content 1</a>).</p></div><div id="S12" class="sec sec-last"><h3 id="S12title">Pathway-based Genome-wide Association Study</h3><p id="P14" class="p p-first">Pathway analysis was performed with the Pathway Analysis by Randomization Incorporating Structure (PARIS) software package(23). SNPs were first assigned to gene boundaries based on genomic location. Genes, in turn, were assigned to functional networks, which were tested for overrepresentation of SNPs that were observed to be nominally associated with change in LVEF in the single-SNP GWAS. Since the goal of pathway-based analysis was to extend on the single-SNP GWAS and identify cumulative effects on change in LVEF that related to multiple SNPs, with individually smaller effects, we set a less stringent threshold and significant SNPs were defined as those with p-values ≤ 0.05 from the discovery GWAS.Biological pathways were defined based on the KEGG Pathway Database.(24) A total of 290 KEGG pathways were evaluated for overrepresentation of SNPs significantly associated with change in LVEF. To determine p-values for overall association of pathways, permutation tests were conducted comparing pathways defined in the KEGG database to random pathways generated from regions across the genome having similar linkage disequilibrium (LD) structure (as predicted based on control individuals of European ancestry available in the HapMap population). We chose to generate random pathways for permutation tests using the LD structure predicted for individuals of European ancestry as the majority of the analysis dataset (~84%) that was evaluated in the single-SNP GWAS, from which the p-values for SNPs were derived, represented this ancestral group. The number of SNPs significantly associated with change in LVEF assigned to each evaluated KEGG pathway were compared to the number of significantly associated SNPs in 3,500 randomly generated pathways. Based on this number of permutation tests, we chose a stringent significance threshold of p&lt;2.86×10<sup>−4</sup> for pathway-based results, which corresponded to a false discovery rate-corrected p-value of ≤ 0.05.</p><p id="P15" class="p p-last">To better understand the relationship of associated pathways to risk for change in LVEF, pathways that were significantly associated were further subjected to permutation-based investigations to identify ‘core’ genes driving overall pathway associations. ‘Core’ genes were defined as genes whose p-value in the context of the biological pathway was p&lt;0.001.</p></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">RESULTS</h2><div id="S14" class="sec sec-first"><h3 id="S14title">Discovery and Replication Cohort Identification</h3><p id="P16" class="p p-first">Search of BioVU identified 385 subjects with anthracycline exposure, measures of LVEF, and available DNA samples (see <a href="#SD4" rid="SD4" class=" supplementary-material">Figure, Supplemental Digital Content 4</a>). Subjects were median age 52 years [interquartile range (IQR) 40 to 61 years], 58% female, and 88% white. Non-Hodgkin’s lymphoma and breast cancer were the most common malignancies. Median baseline LVEF was 64% [IQR 60 to 68%], and the median change in LVEF from baseline was −6% [IQR 0 to −12%] with a range of 22 to −47% (<a href="/pmc/articles/PMC5502740/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>). The median anthracycline exposure (doxorubicin equivalents) was 240 mg/m<sup>2</sup> [IQR 180 to 300 mg/m<sup>2</sup>]. The median time from baseline LVEF to anthracycline exposure was 6 days [IQR 2 to 13 days], and median follow-up between chemotherapy initiation and outcome LVEF was 348 days [IQR 122 to 755 days] (<a href="/pmc/articles/PMC5502740/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). Radionuclide ventriculography and transthoracic echocardiography accounted for over 95% of both pre-chemotherapy (74% radionuclide ventriculography; 24% transthoracic echocardiography) and outcome (50% radionuclide ventriculography; 46% transthoracic echocardiography) LVEF observations. Baseline LVEF and cumulative aanthracycline dose were imputed for 74 (19%) and 2 (0.5%) subjects respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC5502740/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140527606944544" class="figure"><a href="/pmc/articles/PMC5502740/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5502740_nihms870773f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms870773f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5502740/bin/nihms870773f1.jpg"></a></div><div id="largeobj_idm140527606944544" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5502740/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC5502740/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p3">Change in ejection fraction from baseline in discovery GWAS and replication cohorts. In each panel, total doxorubicin equivalents per square meter (mg/m<sup>2</sup>) are shown on the X-axis, and change in left ventricular ejection fraction (LVEF) on the Y-axis. A) Discovery GWAS cohort. B) Replication cohort</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p5">Demographics for Discovery GWAS Cohort (N=385)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140527611937376" class="xtable"><table frame="above" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Parameter</th><th rowspan="1" colspan="1" valign="top" align="left">N (Percent) or Median (IQR)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Female</td><td rowspan="1" colspan="1" valign="top" align="left">223 (58%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age at Start of Chemotherapy (years)</td><td rowspan="1" colspan="1" valign="top" align="left">52 (40 to 61)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Race</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> White</td><td rowspan="1" colspan="1" valign="top" align="left">337 (88%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Black</td><td rowspan="1" colspan="1" valign="top" align="left">30 (8%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Asian</td><td rowspan="1" colspan="1" valign="top" align="left">1 (0.3%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Latino</td><td rowspan="1" colspan="1" valign="top" align="left">4 (1%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Unknown</td><td rowspan="1" colspan="1" valign="top" align="left">13 (3%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Baseline Ejection Fraction (%)</td><td rowspan="1" colspan="1" valign="top" align="left">64 (60 to 68)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Time from Chemotherapy to Outcome LVEF<sup>*</sup> (days)</td><td rowspan="1" colspan="1" valign="top" align="left">348 (122 to 755)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Most Frequent Oncologic Diagnosis</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Non-Hodgkin Lymphoma</td><td rowspan="1" colspan="1" valign="top" align="left">109 (28%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Breast cancer</td><td rowspan="1" colspan="1" valign="top" align="left">78 (20%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> AML</td><td rowspan="1" colspan="1" valign="top" align="left">59 (15%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Sarcoma</td><td rowspan="1" colspan="1" valign="top" align="left">39 (10%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Hodgkin Lymphoma</td><td rowspan="1" colspan="1" valign="top" align="left">28 (7%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Radiation to Chest</td><td rowspan="1" colspan="1" valign="top" align="left">71 (18%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Cumulative Anthracycline Dose (Doxorubicin equiv. mg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">240 (180 to 300)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Change in LVEF</td><td rowspan="1" colspan="1" valign="top" align="left">−6 (0 to −12) (range 22 to −47)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Cardiovascular Risk Factors</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Hypertension</td><td rowspan="1" colspan="1" valign="top" align="left">139 (36%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Dyslipidemia</td><td rowspan="1" colspan="1" valign="top" align="left">76 (20%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left"> Smoking</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  Never</td><td rowspan="1" colspan="1" valign="top" align="left">228 (59%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  Former</td><td rowspan="1" colspan="1" valign="top" align="left">81 (21%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  Current</td><td rowspan="1" colspan="1" valign="top" align="left">76 (20%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Diabetes</td><td rowspan="1" colspan="1" valign="top" align="left">39 (10%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Coronary artery disease</td><td rowspan="1" colspan="1" valign="top" align="left">19 (5%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">BMI<sup>†</sup> (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">28 (24 to 32)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Trastuzumab</td><td rowspan="1" colspan="1" valign="top" align="left">26 (7%)</td></tr></tbody></table></div><div id="largeobj_idm140527611937376" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5502740/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>*</sup>LVEF = Left ventricular ejection fraction;</div><div id="TFN2"><sup>†</sup>BMI = Body mass index</div></div></div><p id="P17" class="p p-last">The replication cohort included 181 PREDICT subjects with adequate DNA samples and complete phenotype data (see <a href="#SD5" rid="SD5" class=" supplementary-material">Figure, Supplemental Digital Content 5</a>). Subjects were median age 53 years [IQR 45 to 61 years], 87% female, and 84% white. Breast cancer was the most common malignancy. The median baseline LVEF was 64% [IQR 60 to 68%], and the median change in LVEF was −4% [IQR 3 to −9%] with a range of 16 to −28% (<a href="/pmc/articles/PMC5502740/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>). The median anthracycline dose was 224 mg/m<sup>2</sup> [IQR 60 to 241 mg/m<sup>2</sup>], with a median follow-up from start of chemotherapy of 217 days [IQR 180 to 364 days] (<a href="/pmc/articles/PMC5502740/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), and XX subjects had prior exposure to chemotherapy</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p8">Demographics for Replication Cohort (N=181)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140527602846976" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="top" align="left">Parameter</th><th rowspan="1" colspan="1" valign="top" align="left">Percent (N) or Median (IQR)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Female</td><td rowspan="1" colspan="1" valign="top" align="left">158 (87%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age at Start of Chemotherapy (years)</td><td rowspan="1" colspan="1" valign="top" align="left">53 (45 to 61)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Race</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> White</td><td rowspan="1" colspan="1" valign="top" align="left">152 (84%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Black</td><td rowspan="1" colspan="1" valign="top" align="left">23 (13%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Asian</td><td rowspan="1" colspan="1" valign="top" align="left">3 (2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Unknown</td><td rowspan="1" colspan="1" valign="top" align="left">3 (2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Baseline LVEF (%)</td><td rowspan="1" colspan="1" valign="top" align="left">64 (60 to 68)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Time from Baseline LVEF to Anthracycline<sup>*</sup> (days)</td><td rowspan="1" colspan="1" valign="top" align="left">6 (2 to 13 days)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Time from Chemotherapy to Outcome LVEF (days)</td><td rowspan="1" colspan="1" valign="top" align="left">217 (180 to 364)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Oncologic Diagnosis</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Breast cancer</td><td rowspan="1" colspan="1" valign="top" align="left">145 (80%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Lymphoma</td><td rowspan="1" colspan="1" valign="top" align="left">32 (18%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Gastrointestinal</td><td rowspan="1" colspan="1" valign="top" align="left">3 (2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Sarcoma</td><td rowspan="1" colspan="1" valign="top" align="left">1 (0.6%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Radiation to Chest</td><td rowspan="1" colspan="1" valign="top" align="left">Not available</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Cumulative Anthracycline Dose (Doxorubicin equiv. mg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">224 (60 to 241)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Change in Ejection Fraction (%)</td><td rowspan="1" colspan="1" valign="top" align="left">−4 (3 to −9) [range 16 to −28]</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left">Cardiovascular Risk Factors</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Hypertension</td><td rowspan="1" colspan="1" valign="top" align="left">61 (34%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Dyslipidemia</td><td rowspan="1" colspan="1" valign="top" align="left">55 (30%)</td></tr><tr><td colspan="2" rowspan="1" valign="top" align="left"> Smoking</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  Never</td><td rowspan="1" colspan="1" valign="top" align="left">106 (59%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  Former</td><td rowspan="1" colspan="1" valign="top" align="left">48 (27%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">  Current</td><td rowspan="1" colspan="1" valign="top" align="left">27 (15%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Diabetes</td><td rowspan="1" colspan="1" valign="top" align="left">25 (14%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left"> Coronary artery disease</td><td rowspan="1" colspan="1" valign="top" align="left">Not available</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">BMI<sup>†</sup> (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">29 (25–34)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Trastuzumab</td><td rowspan="1" colspan="1" valign="top" align="left">25 (14%)</td></tr></tbody></table></div><div id="largeobj_idm140527602846976" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5502740/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><sup>*</sup>LVEF = Left ventricular ejection fraction;</div><div id="TFN4"><sup>†</sup>BMI = Body mass index</div></div></div></div><div id="S15" class="sec"><h3 id="S15title">Discovery GWAS and Replication</h3><p id="P18" class="p p-first-last">After imputation and quality control, 4,429,986 markers were included in the discovery GWAS. A single locus on chromosome 1 (1p32.1) reached genome-wide significance with a p-value of 2.7×10<sup>−8</sup> for the lead SNP rs10443221, which conferred protection (β=4.11; standard error 0.74) from cardiotoxicity (i.e., change in LVEF was 4.11 points higher for each alternate allele). The nearest characterized gene is <em>CYP2J2</em>. Ten other loci had p-values &lt;1.0×10<sup>−5</sup>, including rs7542939 at 1p36.21 (<a href="/pmc/articles/PMC5502740/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>; see <a href="#SD6" rid="SD6" class=" supplementary-material">Figure, Supplemental Digital Content 6</a> and <a href="#SD7" rid="SD7" class=" supplementary-material">7</a>). Lead SNPs from all 11 loci were carried forward for testing in the replication cohort. Results of association testing for discovery and replication are summarized in <a href="/pmc/articles/PMC5502740/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. One locus, 1p36.21, successfully replicated with the lead SNP rs7542939 having a p-value of 0.01. This SNP had an overall MAF of 0.15 and conferred increased risk (overall β=−3.82; standard error 0.77) for a decrease in LVEF. The combined p-value from meta-analysis for this SNP was 6.5×10<sup>−7</sup>. The nearest annotated gene, <em>PRDM2</em>, is approximately 40 kilobases upstream and encodes an H3K9 methyltransferase that regulates gene expression through modification of chromatin at target genes promoters.<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203457">22</a></sup> No association between SNP rs10443221 and change in LVEF was observed in the replication cohort (β=−1.2; standard error 0.80; p=0.14).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC5502740/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140527611939952" class="figure"><a href="/pmc/articles/PMC5502740/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5502740_nihms870773f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms870773f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5502740/bin/nihms870773f2.jpg"></a></div><div id="largeobj_idm140527611939952" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5502740/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC5502740/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p4">Manhattan plot of discovery GWAS of change in left ventricular ejection fraction (LVEF). Results for each variant are organized according to chromosomal position on the X-axis, with -log<sub>10</sub> (p-values) for association of genotype to change LVEF from the discovery cohort on the Y-axis. The horizontal line indicates the <em>a priori</em> threshold for statistical significance.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p11">Results of Association Testing for Discovery and Replication Cohorts</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140527601352336" class="xtable"><table frame="box" rules="all" class="rendered small default_table"><thead><tr><th colspan="4" rowspan="1" valign="top" align="center">Locus Details</th><th colspan="3" rowspan="1" valign="top" align="center">Discovery GWAS</th><th colspan="3" rowspan="1" valign="top" align="center">Replication</th></tr><tr><th rowspan="1" colspan="1" valign="top" align="left">Locus</th><th rowspan="1" colspan="1" valign="top" align="left">SNP</th><th rowspan="1" colspan="1" valign="top" align="left">Nearest Annotated Gene(s)</th><th rowspan="1" colspan="1" valign="top" align="center">Coded Allele</th><th rowspan="1" colspan="1" valign="top" align="center">MAF</th><th rowspan="1" colspan="1" valign="top" align="center">Beta (SE)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th><th rowspan="1" colspan="1" valign="top" align="center">MAF</th><th rowspan="1" colspan="1" valign="top" align="center">Beta (SE)</th><th rowspan="1" colspan="1" valign="top" align="center">p-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">1p32.1</td><td rowspan="1" colspan="1" valign="top" align="left">rs10443221</td><td rowspan="1" colspan="1" valign="top" align="left">HOOK1, CYP2J2, C1orf187</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td><td rowspan="1" colspan="1" valign="top" align="center">4.11 (0.74)</td><td rowspan="1" colspan="1" valign="top" align="center">2.7 e-8</td><td rowspan="1" colspan="1" valign="top" align="center">0.34</td><td rowspan="1" colspan="1" valign="top" align="center">−1.2 (0.80)</td><td rowspan="1" colspan="1" valign="top" align="center">0.14</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">1p36.21</td><td rowspan="1" colspan="1" valign="top" align="left">rs7542939</td><td rowspan="1" colspan="1" valign="top" align="left">PRDM2</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.15</td><td rowspan="1" colspan="1" valign="top" align="center">−4.97 (1.10)</td><td rowspan="1" colspan="1" valign="top" align="center">5.9 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.14</td><td rowspan="1" colspan="1" valign="top" align="center">−2.7 (1.08)</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">2p12</td><td rowspan="1" colspan="1" valign="top" align="left">rs78000710</td><td rowspan="1" colspan="1" valign="top" align="left">LRRTM4</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">−6.60 (1.52)</td><td rowspan="1" colspan="1" valign="top" align="center">1.4 e-5</td><td rowspan="1" colspan="1" valign="top" align="center">0.08</td><td rowspan="1" colspan="1" valign="top" align="center">−0.12 (1.50)</td><td rowspan="1" colspan="1" valign="top" align="center">0.94</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">3q28</td><td rowspan="1" colspan="1" valign="top" align="left">rs7635904</td><td rowspan="1" colspan="1" valign="top" align="left">TPRG1</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.08</td><td rowspan="1" colspan="1" valign="top" align="center">−5.82 (1.28)</td><td rowspan="1" colspan="1" valign="top" align="center">5.3 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.12</td><td rowspan="1" colspan="1" valign="top" align="center">−0.85 (1.17)</td><td rowspan="1" colspan="1" valign="top" align="center">0.47</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">6p21.1</td><td rowspan="1" colspan="1" valign="top" align="left">rs990963</td><td rowspan="1" colspan="1" valign="top" align="left">LRRTM4</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.39</td><td rowspan="1" colspan="1" valign="top" align="center">−3.47 (0.78)</td><td rowspan="1" colspan="1" valign="top" align="center">7.8 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.39</td><td rowspan="1" colspan="1" valign="top" align="center">−0.18 (0.79)</td><td rowspan="1" colspan="1" valign="top" align="center">0.82</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">7p21.1</td><td rowspan="1" colspan="1" valign="top" align="left">rs7801891</td><td rowspan="1" colspan="1" valign="top" align="left">AHR, AGR3</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.08</td><td rowspan="1" colspan="1" valign="top" align="center">6.21 (1.33)</td><td rowspan="1" colspan="1" valign="top" align="center">3.0 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">0.33 (1.50)</td><td rowspan="1" colspan="1" valign="top" align="center">0.83</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">12q24.13</td><td rowspan="1" colspan="1" valign="top" align="left">rs11066861</td><td rowspan="1" colspan="1" valign="top" align="left">RBM19</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">−7.10 (1.58)</td><td rowspan="1" colspan="1" valign="top" align="center">7.1 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">1.18 (1.64)</td><td rowspan="1" colspan="1" valign="top" align="center">0.47</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">13q31.3</td><td rowspan="1" colspan="1" valign="top" align="left">rs34223702</td><td rowspan="1" colspan="1" valign="top" align="left">LINC00379</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">−8.32 (1.72)</td><td rowspan="1" colspan="1" valign="top" align="center">1.4 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">−1.11 (1.45)</td><td rowspan="1" colspan="1" valign="top" align="center">0.45</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">15q13.1</td><td rowspan="1" colspan="1" valign="top" align="left">rs7179489</td><td rowspan="1" colspan="1" valign="top" align="left">FAM189A1</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td><td rowspan="1" colspan="1" valign="top" align="center">3.29 (0.75)</td><td rowspan="1" colspan="1" valign="top" align="center">1.3 e-5</td><td rowspan="1" colspan="1" valign="top" align="center">0.40</td><td rowspan="1" colspan="1" valign="top" align="center">0.22 (0.78)</td><td rowspan="1" colspan="1" valign="top" align="center">0.77</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">16q24.1</td><td rowspan="1" colspan="1" valign="top" align="left">rs55669225</td><td rowspan="1" colspan="1" valign="top" align="left">LINC00917</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">−6.51 (1.47)</td><td rowspan="1" colspan="1" valign="top" align="center">9.3 e-6</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td><td rowspan="1" colspan="1" valign="top" align="center">−0.86 (1.69)</td><td rowspan="1" colspan="1" valign="top" align="center">0.61</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">19q12</td><td rowspan="1" colspan="1" valign="top" align="left">rs12984615</td><td rowspan="1" colspan="1" valign="top" align="left">URI1</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">0.49</td><td rowspan="1" colspan="1" valign="top" align="center">−3.22 (0.77)</td><td rowspan="1" colspan="1" valign="top" align="center">3.0 e-5</td><td rowspan="1" colspan="1" valign="top" align="center">0.51</td><td rowspan="1" colspan="1" valign="top" align="center">−1.30 (0.73)</td><td rowspan="1" colspan="1" valign="top" align="center">0.08</td></tr></tbody></table></div><div id="largeobj_idm140527601352336" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5502740/table/T3/?report=objectonly">Open in a separate window</a></div></div></div><div id="S16" class="sec sec-last"><h3 id="S16title">Pathway-based Genome-Wide Association Study</h3><p id="P19" class="p p-first-last">There were 18 KEGG pathways with strong evidence (p&lt;2.86×10<sup>−4</sup>) of enrichment for SNPs associated with changes in LVEF (see <a href="#SD8" rid="SD8" class=" supplementary-material">Table, Supplemental Digital Content 8</a>). Five pathways were directly related to cellular metabolism and mitochondrial function, including: <em>synthesis and degradation of ketone bodies, ubiquinone and other terpenoid-quinone biosynthesis, D-Glutamine and D-glutamate metabolism, PPAR signaling pathway,</em> and <em>aminoacyl-tRNA biosynthesis</em> (whose association was driven by genes coding for mitochondrial aminoacyl-tRNA synthetases). Associations of five additional pathways, <em>N-glycan biosynthesis, glycosaminoglycan degradation, Wnt signaling, notch signaling,</em> and <em>axon guidance</em> were driven by genes previously implicated in cardiac remodeling. Also enriched was the DNA repair pathway <em>base excision and repair.</em></p></div></div><div id="S17" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S17title">DISCUSSION</h2><p id="P20" class="p p-first">We conducted a GWAS and pathway analysis of change in LVEF after exposure to anthracycline chemotherapy. Our GWAS results suggest a novel candidate susceptibility locus at chromosome 1p36.21 near <em>PRDM2</em>, and pathway analysis highlights the multifactorial nature of anthracycline cardiotoxicity and points toward processes involved in cellular metabolism/energetics, myocardial remodeling, and genome repair as central contributors to susceptibility.</p><p id="P21">While we cannot say with certainty that the observed association at 1p36.21 is functionally related to <em>PRDM2,</em> there are several features that make it a biologically plausible candidate gene. PRDM2 is critical for BRCA1-dependent repair of DNA double-strand breaks,<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203430">23</a></sup> and impairment of this mechanism exacerbates doxorubicin cardiotoxicity in mice.<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203449">24</a></sup> Additionally, PRDM2 is a transcriptional regulator of heme-oxygenase-1<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203441">25</a></sup>, which, in addition to it’s role in protection from oxidative stress<sup><a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203460">26</a>,<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203429">27</a></sup>, has been shown to facilitate repair of doxorubicin-induced DNA double-strand breaks <em>in vitro</em><sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203435">28</a></sup> and reduce cardiomyocyte apoptosis in doxorubicin-exposed mice.<sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203455">29</a></sup></p><p id="P22">Although the association between rs10443221 and change in LVEF observed in the discovery GWAS was not replicated, <em>CYP2J2</em> also has biologic plausibility as a candidate gene. CYP2J2 converts arachidonic acid to epoxyeicosatrienoic acids (EETs), whose cardiovascular effects include systemic and coronary vasodilation,<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203461">30</a></sup> anti-inflammatory actions,<sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203428">31</a></sup> and promotion of angiogenesis.<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203462">32</a></sup> Exogenous EETs attenuate doxorubicin-induced mitochondrial damage <em>in vitro</em>, and mice with cardiac specific overexpression of human <em>CYP2J2</em> show reduced cardiomyocyte apoptosis, lower levels of biomarkers of myocardial injury and oxidative stress, and improved cardiac function after exposure to anthracyclines.<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203426">33</a></sup> These functional data may support the measurement of EET’s and CYP2J2 function in future studies of anthracycline cardiotoxicity.</p><p id="P23">It was expected that common variants may have cumulative effects on LV function, and that genetic factors contributing smaller effects (OR≤1.5) would be overlooked in the typical single-SNP approach to analysis of GWAS data. Pathway-based analysis identified 18 KEGG pathways associated with change in LV function. DNA injury is an important proximal effect of anthracyclines. Therefore, it is not unexpected that associations with pathways involved in DNA repair. Similarly, the heart has very high energy requirements, and heart failure from any cause, particularly when advanced, is associated with myocardial energy depletion, derangement of mitochondrial function and biogenesis, and a general shift in substrate preference from fatty acids to glucose.<sup><a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203453">34</a>,<a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203432">35</a></sup> The observed associations in energetic pathways may suggest that susceptible individuals have less “metabolic reserve” in the face of myocardial injury. Pathway analysis also identified several cellular components and processes previously implicated in myocardial remodeling and response to injury, including glycosylation<sup><a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203458">36</a>,<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203464">37</a></sup>, constituents of the extracellular matrix (ECM) <sup><a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203443">38</a></sup>, and proteins involved in ECM-receptor interaction.<sup><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203438">39</a>–<a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203450">41</a></sup> Additionally, two important signaling pathways, wnt and notch, also showed evidence for enrichment. The role of both pathways in cancer and metastasis is well established;<sup><a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203442">42</a>,<a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203440">43</a></sup> they are also important for induction of pathologic hypertrophy, cardiac remodeling, and response to various forms of myocardial injury including infarction and pressure overload.<sup><a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203434">44</a>–<a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203448">48</a></sup> The diversity of pathways implicated reinforce the complexity of anthracycline cardiotoxicity and may point toward therapeutic targets.</p><p id="P24">It is interesting that we did not detect associations with many previously implicated susceptibility factors for anthracycline related cardiotoxicity.<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203423">11</a>,<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203425">13</a>,<a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203427">49</a></sup> Difficulty replicating associations between candidate variants and important human phenotypes has been described.<sup><a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625203437">50</a></sup> It may be that we were underpowered to detect small effect sizes. It is also possible that some published associations are false positives. However, this observation may be related to important differences among studies including population demographics, treatment, comorbidities, follow-up duration, and definition of toxicity.</p><p id="P25" class="p p-last">Results of our study should be interpreted within its limitations. The cohorts used are relatively small, and we were likely underpowered to detect effects of modest size. Additionally, variability in LVEF measurements due to inherent limitations of cardiac imaging and lack of standardized protocols in the discovery cohort (e.g., assessments were clinically indicated and not at pre-specified intervals, contrast was not universally used, LVEF measurements were made using both quantitative and visual estimation methods, and use of different modalities for pre- and post-therapy LVEF determination) could have introduced bias. Finally, we did not perform functional studies to further establish a mechanistic link between the locus tagged by SNP rs7542939 and cardiotoxicity. However, previously published data regarding nearby genes and the availability of an independent replication cohort add confidence to the observed association.</p></div><div id="S18" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S18title">Conclusions</h2><p id="P26" class="p p-first-last">The genomic architecture of anthracycline cardiotoxicity is complex. Using GWAS we identified a novel susceptibility locus near <em>PRDM2</em>. Pathway analysis suggested that genome repair, metabolism, and pathways relevant for cardiac remodeling influence susceptibility to anthracycline cardiotoxicity. Our findings extend current understanding by identifying a novel risk locus and emphasizing the multifactorial nature of anthracycline cardiotoxicity. This work helps to frame findings from prior candidate studies into a paradigm of genomic injury followed by progressive metabolic and myocardial remodeling. Finally, our findings provide mechanistic insight into anthracycline cardiotoxicity and suggest testable hypotheses for detection and prevention of this adverse effect.</p></div><div id="S19" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supplemental Digital Content_1</h4><div class="sup-box half_rhythm" id="d36e810"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_1.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(54K, docx)</sup></div></div><div class="sec suppmat" id="SD2"><h4>Supplemental Digital Content_2</h4><div class="sup-box half_rhythm" id="d36e814"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_2.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(2.2M, docx)</sup></div></div><div class="sec suppmat" id="SD3"><h4>Supplemental Digital Content_3</h4><div class="sup-box half_rhythm" id="d36e818"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_3.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(1.7M, docx)</sup></div></div><div class="sec suppmat" id="SD4"><h4>Supplemental Digital Content_4</h4><div class="sup-box half_rhythm" id="d36e822"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_4.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(88K, docx)</sup></div></div><div class="sec suppmat" id="SD5"><h4>Supplemental Digital Content_5</h4><div class="sup-box half_rhythm" id="d36e826"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_5.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(76K, docx)</sup></div></div><div class="sec suppmat" id="SD6"><h4>Supplemental Digital Content_6</h4><div class="sup-box half_rhythm" id="d36e830"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_6.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(1.8M, docx)</sup></div></div><div class="sec suppmat" id="SD7"><h4>Supplemental Digital Content_7</h4><div class="sup-box half_rhythm" id="d36e834"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_7.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(1.8M, docx)</sup></div></div><div class="sec suppmat" id="SD8"><h4>Supplemental Digital Content_8</h4><div class="sup-box half_rhythm" id="d36e838"><a href="/pmc/articles/PMC5502740/bin/NIHMS870773-supplement-Supplemental_Digital_Content_8.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(97K, docx)</sup></div></div></div><div id="S20" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S20title">Acknowledgments</h2><div class="sec"><p id="__p1">Supported in part by American Heart Association Fellow-to-Faculty Award 13FTF16810038 (QSW), NIH grant RC2GM092618 (DJL, MJF), Vanderbilt training grant T32 GM07569 (JHK), Vanderbilt training grant T32 <a id="__tag_783122476" class="tag_hotlink" href="/nuccore/HL105334" ref="/nuccore/HL105334"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"HL105334","term_id":"1051677353","term_text":"HL105334"}}</span>HL105334</a> (QSW) American Heart Association Post-doctoral grant 15POST22660017 (JHK and SLV), an ACCP RI Futures Grants Award from the American College of Clinical Pharmacy (JHK), KL2 TR 000446 from NCATS/NIH (SLV). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center’s BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1-TR000445 from National Center for Advancing Translational Sciences/National Institutes of Health (<a href="http://www.nih.gov/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.nih.gov/</a>).</p></div></div><div id="idm140527608170576" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140527608170576title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"></p><p id="__p2" class="p p-first-last">Conflicts of interest: None declared.</p><p></p></div></div><div id="idm140527615943856" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140527615943856title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W, et al.  Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children’s Oncology Group. <span><span class="ref-journal">PEDIATRICS. </span>2008;<span class="ref-vol">121</span>:e387–96.</span> [<a href="/pubmed/18187811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PEDIATRICS&amp;title=Monitoring+for+cardiovascular+disease+in+survivors+of+childhood+cancer:+report+from+the+Cardiovascular+Disease+Task+Force+of+the+Children’s+Oncology+Group&amp;author=SM+Shankar&amp;author=N+Marina&amp;author=MM+Hudson&amp;author=DC+Hodgson&amp;author=MJ+Adams&amp;volume=121&amp;publication_year=2008&amp;pages=e387-96&amp;pmid=18187811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Geisberg CA, Sawyer DB. Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage. <span><span class="ref-journal">Curr Hypertens Rep. </span>2010;<span class="ref-vol">12</span>:404–410.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3999517/">PMC free article</a>]</span> [<a href="/pubmed/20842465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Hypertens+Rep&amp;title=Mechanisms+of+anthracycline+cardiotoxicity+and+strategies+to+decrease+cardiac+damage&amp;author=CA+Geisberg&amp;author=DB+Sawyer&amp;volume=12&amp;publication_year=2010&amp;pages=404-410&amp;pmid=20842465&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Forrest GL, Gonzalez B, Tseng W, Li X, Mann J. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice. <span><span class="ref-journal">Cancer Res. </span>2000;<span class="ref-vol">60</span>:5158–5164.</span> [<a href="/pubmed/11016643" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Human+carbonyl+reductase+overexpression+in+the+heart+advances+the+development+of+doxorubicin-induced+cardiotoxicity+in+transgenic+mice&amp;author=GL+Forrest&amp;author=B+Gonzalez&amp;author=W+Tseng&amp;author=X+Li&amp;author=J+Mann&amp;volume=60&amp;publication_year=2000&amp;pages=5158-5164&amp;pmid=11016643&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Dell’Acqua G, Polishchuck R, Fallon JT, Gordon JW. Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain/human multiple drug resistance 1 fusion gene. <span><span class="ref-journal">Hum Gene Ther. </span>1999;<span class="ref-vol">10</span>:1269–1279.</span> [<a href="/pubmed/10365658" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Gene+Ther&amp;title=Cardiac+resistance+to+adriamycin+in+transgenic+mice+expressing+a+rat+alpha-cardiac+myosin+heavy+chain/human+multiple+drug+resistance+1+fusion+gene&amp;author=G+Dell’Acqua&amp;author=R+Polishchuck&amp;author=JT+Fallon&amp;author=JW+Gordon&amp;volume=10&amp;publication_year=1999&amp;pages=1269-1279&amp;pmid=10365658&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Zhang S, Liu X, Bawa-Khalfe T, Lu L-S, Lyu YL, Liu LF, et al.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity. <span><span class="ref-journal">Nature Medicine. </span>2012;<span class="ref-vol">18</span>:1639–1642.</span> [<a href="/pubmed/23104132" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Identification+of+the+molecular+basis+of+doxorubicin-induced+cardiotoxicity&amp;author=S+Zhang&amp;author=X+Liu&amp;author=T+Bawa-Khalfe&amp;author=L-S+Lu&amp;author=YL+Lyu&amp;volume=18&amp;publication_year=2012&amp;pages=1639-1642&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, et al.  Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. <span><span class="ref-journal">Clin Cancer Res. </span>2014;<span class="ref-vol">20</span>:4873–4881.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4167185/">PMC free article</a>]</span> [<a href="/pubmed/24714774" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Mitochondrial+topoisomerase+I+(top1mt)+is+a+novel+limiting+factor+of+doxorubicin+cardiotoxicity&amp;author=S+Khiati&amp;author=I+Dalla+Rosa&amp;author=C+Sourbier&amp;author=X+Ma&amp;author=VA+Rao&amp;volume=20&amp;publication_year=2014&amp;pages=4873-4881&amp;pmid=24714774&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Abdel-aleem S, el-Merzabani MM, Sayed-Ahmed M, Taylor DA, Lowe JE. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. <span><span class="ref-journal">Journal of molecular and cellular cardiology. </span>1997;<span class="ref-vol">29</span>:789–797.</span> [<a href="/pubmed/9140835" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+molecular+and+cellular+cardiology&amp;title=Acute+and+chronic+effects+of+adriamycin+on+fatty+acid+oxidation+in+isolated+cardiac+myocytes&amp;author=S+Abdel-aleem&amp;author=MM+el-Merzabani&amp;author=M+Sayed-Ahmed&amp;author=DA+Taylor&amp;author=JE+Lowe&amp;volume=29&amp;publication_year=1997&amp;pages=789-797&amp;pmid=9140835&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Wojnowski L, Kulle B, Schirmer M, Schluter G, Schmidt A, Rosenberger A, et al.  NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. <span><span class="ref-journal">Circulation. </span>2005;<span class="ref-vol">112</span>:3754–3762.</span> [<a href="/pubmed/16330681" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=NAD(P)H+oxidase+and+multidrug+resistance+protein+genetic+polymorphisms+are+associated+with+doxorubicin-induced+cardiotoxicity&amp;author=L+Wojnowski&amp;author=B+Kulle&amp;author=M+Schirmer&amp;author=G+Schluter&amp;author=A+Schmidt&amp;volume=112&amp;publication_year=2005&amp;pages=3754-3762&amp;pmid=16330681&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Rajic V, Aplenc R, Debeljak M, Prestor VV, Karas-Kuzelicki N, Mlinaric-Rascan I, et al.  Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood. <span><span class="ref-journal">Leuk Lymphoma. </span>2009;<span class="ref-vol">50</span>:1693–1698.</span> [<a href="/pubmed/19863340" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Lymphoma&amp;title=Influence+of+the+polymorphism+in+candidate+genes+on+late+cardiac+damage+in+patients+treated+due+to+acute+leukemia+in+childhood&amp;author=V+Rajic&amp;author=R+Aplenc&amp;author=M+Debeljak&amp;author=VV+Prestor&amp;author=N+Karas-Kuzelicki&amp;volume=50&amp;publication_year=2009&amp;pages=1693-1698&amp;pmid=19863340&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Blanco JG, Sun C-L, Landier W, Chen L, Esparza-Duran D, Leisenring W, et al.  Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children’s Oncology Group. <span><span class="ref-journal">J Clin Oncol. </span>2012;<span class="ref-vol">30</span>:1415–1421.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3383117/">PMC free article</a>]</span> [<a href="/pubmed/22124095" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Anthracycline-related+cardiomyopathy+after+childhood+cancer:+role+of+polymorphisms+in+carbonyl+reductase+genes--a+report+from+the+Children’s+Oncology+Group&amp;author=JG+Blanco&amp;author=C-L+Sun&amp;author=W+Landier&amp;author=L+Chen&amp;author=D+Esparza-Duran&amp;volume=30&amp;publication_year=2012&amp;pages=1415-1421&amp;pmid=22124095&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Visscher H, Ross CJD, Rassekh SR, Barhdadi A, Dubé M-P, Al-Saloos H, et al.  Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. <span><span class="ref-journal">J Clin Oncol. </span>2012;<span class="ref-vol">30</span>:1422–1428.</span> [<a href="/pubmed/21900104" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Pharmacogenomic+prediction+of+anthracycline-induced+cardiotoxicity+in+children&amp;author=H+Visscher&amp;author=CJD+Ross&amp;author=SR+Rassekh&amp;author=A+Barhdadi&amp;author=M-P+Dubé&amp;volume=30&amp;publication_year=2012&amp;pages=1422-1428&amp;pmid=21900104&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Lubieniecka JM, Graham J, Heffner D, Mottus R, Reid R, Hogge D, et al.  A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor. <span><span class="ref-journal">Frontiers in Genetics. </span>2013;<span class="ref-vol">4</span>:231.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3822292/">PMC free article</a>]</span> [<a href="/pubmed/24273552" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers+in+Genetics&amp;title=A+discovery+study+of+daunorubicin+induced+cardiotoxicity+in+a+sample+of+acute+myeloid+leukemia+patients+prioritizes+P450+oxidoreductase+polymorphisms+as+a+potential+risk+factor&amp;author=JM+Lubieniecka&amp;author=J+Graham&amp;author=D+Heffner&amp;author=R+Mottus&amp;author=R+Reid&amp;volume=4&amp;publication_year=2013&amp;pages=231&amp;pmid=24273552&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Aminkeng F, Bhavsar AP, Visscher H, Rassekh SR, Li Y, Lee JW, et al.  A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:1079–1084.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4552570/">PMC free article</a>]</span> [<a href="/pubmed/26237429" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+coding+variant+in+RARG+confers+susceptibility+to+anthracycline-induced+cardiotoxicity+in+childhood+cancer&amp;author=F+Aminkeng&amp;author=AP+Bhavsar&amp;author=H+Visscher&amp;author=SR+Rassekh&amp;author=Y+Li&amp;volume=47&amp;publication_year=2015&amp;pages=1079-1084&amp;pmid=26237429&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, et al.  Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. <span><span class="ref-journal">JAMA. </span>2009;<span class="ref-vol">302</span>:168–178.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2975567/">PMC free article</a>]</span> [<a href="/pubmed/19584346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Genetic+variants+associated+with+cardiac+structure+and+function:+a+meta-analysis+and+replication+of+genome-wide+association+data&amp;author=RS+Vasan&amp;author=NL+Glazer&amp;author=JF+Felix&amp;author=W+Lieb&amp;author=PS+Wild&amp;volume=302&amp;publication_year=2009&amp;pages=168-178&amp;pmid=19584346&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al.  Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy. <span><span class="ref-journal">Circulation. </span>2015;<span class="ref-vol">131</span>:1981–1988.</span> [<a href="/pubmed/25948538" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Early+Detection+of+Anthracycline+Cardiotoxicity+and+Improvement+With+Heart+Failure+Therapy&amp;author=D+Cardinale&amp;author=A+Colombo&amp;author=G+Bacchiani&amp;author=I+Tedeschi&amp;author=CA+Meroni&amp;volume=131&amp;publication_year=2015&amp;pages=1981-1988&amp;pmid=25948538&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, et al.  Development of a large-scale de-identified DNA biobank to enable personalized medicine. <span><span class="ref-journal">Clinical Pharmacology &amp; Therapeutics. </span>2008;<span class="ref-vol">84</span>:362–369.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3763939/">PMC free article</a>]</span> [<a href="/pubmed/18500243" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clinical+Pharmacology+&amp;+Therapeutics&amp;title=Development+of+a+large-scale+de-identified+DNA+biobank+to+enable+personalized+medicine&amp;author=DM+Roden&amp;author=JM+Pulley&amp;author=MA+Basford&amp;author=GR+Bernard&amp;author=EW+Clayton&amp;volume=84&amp;publication_year=2008&amp;pages=362-369&amp;pmid=18500243&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Bowton E, Field JR, Wang S, Schildcrout JS, Van Driest SL, Delaney JT, et al.  Biobanks and electronic medical records: enabling cost-effective research. <span><span class="ref-journal">Sci Transl Med. </span>2014;<span class="ref-vol">6</span>:234cm3–234cm3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4226414/">PMC free article</a>]</span> [<a href="/pubmed/24786321" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Biobanks+and+electronic+medical+records:+enabling+cost-effective+research&amp;author=E+Bowton&amp;author=JR+Field&amp;author=S+Wang&amp;author=JS+Schildcrout&amp;author=SL+Van+Driest&amp;volume=6&amp;publication_year=2014&amp;pages=234cm3-234cm3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Altman AJ.  <span class="ref-journal">Supportive Care of Children with Cancer.</span> JHU Press; 2004.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Supportive+Care+of+Children+with+Cancer&amp;author=AJ+Altman&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000529.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689936/">PMC free article</a>]</span> [<a href="/pubmed/19543373" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=A+flexible+and+accurate+genotype+imputation+method+for+the+next+generation+of+genome-wide+association+studies&amp;author=BN+Howie&amp;author=P+Donnelly&amp;author=J+Marchini&amp;volume=5&amp;publication_year=2009&amp;pages=e1000529&amp;pmid=19543373&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Yaspan BL, Bush WS, Torstenson ES, Ma D, Pericak-Vance MA, Ritchie MD, et al.  Genetic analysis of biological pathway data through genomic randomization. <span><span class="ref-journal">Hum Genet. </span>2011;<span class="ref-vol">129</span>:563–571.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3107984/">PMC free article</a>]</span> [<a href="/pubmed/21279722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Genet&amp;title=Genetic+analysis+of+biological+pathway+data+through+genomic+randomization&amp;author=BL+Yaspan&amp;author=WS+Bush&amp;author=ES+Torstenson&amp;author=D+Ma&amp;author=MA+Pericak-Vance&amp;volume=129&amp;publication_year=2011&amp;pages=563-571&amp;pmid=21279722&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. <span><span class="ref-journal">Nucleic Acids Res. </span>2000;<span class="ref-vol">28</span>:27–30.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC102409/">PMC free article</a>]</span> [<a href="/pubmed/10592173" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=KEGG:+kyoto+encyclopedia+of+genes+and+genomes&amp;author=M+Kanehisa&amp;author=S+Goto&amp;volume=28&amp;publication_year=2000&amp;pages=27-30&amp;pmid=10592173&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Kim K-C, Geng L, Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:7619–7623.</span> [<a href="/pubmed/14633678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Inactivation+of+a+histone+methyltransferase+by+mutations+in+human+cancers&amp;author=K-C+Kim&amp;author=L+Geng&amp;author=S+Huang&amp;volume=63&amp;publication_year=2003&amp;pages=7619-7623&amp;pmid=14633678&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Khurana S, Kruhlak MJ, Kim J, Tran AD, Liu J, Nyswaner K, et al.  A Macrohistone Variant Links Dynamic Chromatin Compaction to BRCA1-Dependent Genome Maintenance. <span><span class="ref-journal">CellReports. </span>2014;<span class="ref-vol">8</span>:1049–1062.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4154351/">PMC free article</a>]</span> [<a href="/pubmed/25131201" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CellReports&amp;title=A+Macrohistone+Variant+Links+Dynamic+Chromatin+Compaction+to+BRCA1-Dependent+Genome+Maintenance&amp;author=S+Khurana&amp;author=MJ+Kruhlak&amp;author=J+Kim&amp;author=AD+Tran&amp;author=J+Liu&amp;volume=8&amp;publication_year=2014&amp;pages=1049-1062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, et al.  BRCA1 is an essential regulator of heart function and survival following myocardial infarction. <span><span class="ref-journal">Nature Communications. </span>2011;<span class="ref-vol">2</span>:593.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3247816/">PMC free article</a>]</span> [<a href="/pubmed/22186889" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Communications&amp;title=BRCA1+is+an+essential+regulator+of+heart+function+and+survival+following+myocardial+infarction&amp;author=PC+Shukla&amp;author=KK+Singh&amp;author=A+Quan&amp;author=M+Al-Omran&amp;author=H+Teoh&amp;volume=2&amp;publication_year=2011&amp;pages=593&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Muraosa Y, Takahashi K, Yoshizawa M, Shibahara S. cDNA cloning of a novel protein containing two zinc-finger domains that may function as a transcription factor for the human heme-oxygenase-1 gene. <span><span class="ref-journal">Eur J Biochem. </span>1996;<span class="ref-vol">235</span>:471–479.</span> [<a href="/pubmed/8654390" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Biochem&amp;title=cDNA+cloning+of+a+novel+protein+containing+two+zinc-finger+domains+that+may+function+as+a+transcription+factor+for+the+human+heme-oxygenase-1+gene&amp;author=Y+Muraosa&amp;author=K+Takahashi&amp;author=M+Yoshizawa&amp;author=S+Shibahara&amp;volume=235&amp;publication_year=1996&amp;pages=471-479&amp;pmid=8654390&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. <span><span class="ref-journal">Am J Respir Cell Mol Biol. </span>1996;<span class="ref-vol">15</span>:9–19.</span> [<a href="/pubmed/8679227" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Cell+Mol+Biol&amp;title=Heme+oxygenase-1:+function,+regulation,+and+implication+of+a+novel+stress-inducible+protein+in+oxidant-induced+lung+injury&amp;author=AM+Choi&amp;author=J+Alam&amp;volume=15&amp;publication_year=1996&amp;pages=9-19&amp;pmid=8679227&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. <span><span class="ref-journal">Am J Physiol. </span>1999;<span class="ref-vol">276</span>:L688–94.</span> [<a href="/pubmed/10198367" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;title=Carbon+monoxide+provides+protection+against+hyperoxic+lung+injury&amp;author=LE+Otterbein&amp;author=LL+Mantell&amp;author=AM+Choi&amp;volume=276&amp;publication_year=1999&amp;pages=L688-94&amp;pmid=10198367&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Otterbein LE, Hedblom A, Harris C, Csizmadia E, Gallo D, Wegiel B. Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein. <span><span class="ref-journal">Proceedings of the National Academy of Sciences. </span>2011;<span class="ref-vol">108</span>:14491–14496.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3167547/">PMC free article</a>]</span> [<a href="/pubmed/21849621" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences&amp;title=Heme+oxygenase-1+and+carbon+monoxide+modulate+DNA+repair+through+ataxia-telangiectasia+mutated+(ATM)+protein&amp;author=LE+Otterbein&amp;author=A+Hedblom&amp;author=C+Harris&amp;author=E+Csizmadia&amp;author=D+Gallo&amp;volume=108&amp;publication_year=2011&amp;pages=14491-14496&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Gu J, Song Z-P, Gui D-M, Hu W, Chen Y-G, Zhang D-D. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction. <span><span class="ref-journal">Cardiovasc Toxicol. </span>2012;<span class="ref-vol">12</span>:341–349.</span> [<a href="/pubmed/22763982" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc+Toxicol&amp;title=Resveratrol+attenuates+doxorubicin-induced+cardiomyocyte+apoptosis+in+lymphoma+nude+mice+by+heme+oxygenase-1+induction&amp;author=J+Gu&amp;author=Z-P+Song&amp;author=D-M+Gui&amp;author=W+Hu&amp;author=Y-G+Chen&amp;volume=12&amp;publication_year=2012&amp;pages=341-349&amp;pmid=22763982&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, et al.  Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. <span><span class="ref-journal">Circulation. </span>2003;<span class="ref-vol">107</span>:769–776.</span> [<a href="/pubmed/12578883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Endothelium-derived+hyperpolarizing+factor+in+human+internal+mammary+artery+is+11,12-epoxyeicosatrienoic+acid+and+causes+relaxation+by+activating+smooth+muscle+BK(Ca)+channels&amp;author=SL+Archer&amp;author=FS+Gragasin&amp;author=X+Wu&amp;author=S+Wang&amp;author=S+McMurtry&amp;volume=107&amp;publication_year=2003&amp;pages=769-776&amp;pmid=12578883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, et al.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">285</span>:1276–1279.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2720027/">PMC free article</a>]</span> [<a href="/pubmed/10455056" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Anti-inflammatory+properties+of+cytochrome+P450+epoxygenase-derived+eicosanoids&amp;author=K+Node&amp;author=Y+Huo&amp;author=X+Ruan&amp;author=B+Yang&amp;author=M+Spiecker&amp;volume=285&amp;publication_year=1999&amp;pages=1276-1279&amp;pmid=10455056&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Fleming I. Epoxyeicosatrienoic acids, cell signaling and angiogenesis. <span><span class="ref-journal">Prostaglandins Other Lipid Mediat. </span>2007;<span class="ref-vol">82</span>:60–67.</span> [<a href="/pubmed/17164133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Other+Lipid+Mediat&amp;title=Epoxyeicosatrienoic+acids,+cell+signaling+and+angiogenesis&amp;author=I+Fleming&amp;volume=82&amp;publication_year=2007&amp;pages=60-67&amp;pmid=17164133&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Zhang Y, El-Sikhry H, Chaudhary KR, Batchu SN, Shayeganpour A, Jukar TO, et al.  Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity. <span><span class="ref-journal">Am J Physiol Heart Circ Physiol. </span>2009;<span class="ref-vol">297</span>:H37–46.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2711738/">PMC free article</a>]</span> [<a href="/pubmed/19429816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&amp;title=Overexpression+of+CYP2J2+provides+protection+against+doxorubicin-induced+cardiotoxicity&amp;author=Y+Zhang&amp;author=H+El-Sikhry&amp;author=KR+Chaudhary&amp;author=SN+Batchu&amp;author=A+Shayeganpour&amp;volume=297&amp;publication_year=2009&amp;pages=H37-46&amp;pmid=19429816&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Beer M, Seyfarth T, Sandstede J, Landschütz W, Lipke C, Köstler H, et al.  Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. <span><span class="ref-journal">JAC. </span>2002;<span class="ref-vol">40</span>:1267–1274.</span> [<a href="/pubmed/12383574" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAC&amp;title=Absolute+concentrations+of+high-energy+phosphate+metabolites+in+normal,+hypertrophied,+and+failing+human+myocardium+measured+noninvasively+with+(31)P-SLOOP+magnetic+resonance+spectroscopy&amp;author=M+Beer&amp;author=T+Seyfarth&amp;author=J+Sandstede&amp;author=W+Landschütz&amp;author=C+Lipke&amp;volume=40&amp;publication_year=2002&amp;pages=1267-1274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Doenst T, Pytel G, Schrepper A, Amorim P, Färber G, Shingu Y, et al.  Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. <span><span class="ref-journal">Cardiovascular Research. </span>2010;<span class="ref-vol">86</span>:461–470.</span> [<a href="/pubmed/20035032" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovascular+Research&amp;title=Decreased+rates+of+substrate+oxidation+ex+vivo+predict+the+onset+of+heart+failure+and+contractile+dysfunction+in+rats+with+pressure+overload&amp;author=T+Doenst&amp;author=G+Pytel&amp;author=A+Schrepper&amp;author=P+Amorim&amp;author=G+Färber&amp;volume=86&amp;publication_year=2010&amp;pages=461-470&amp;pmid=20035032&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Liddy KA, White MY, Cordwell SJ. Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics. <span><span class="ref-journal">Genome Medicine. </span>2013;<span class="ref-vol">5</span>:20–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3706772/">PMC free article</a>]</span> [<a href="/pubmed/23445784" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Medicine&amp;title=Functional+decorations:+post-translational+modifications+and+heart+disease+delineated+by+targeted+proteomics&amp;author=KA+Liddy&amp;author=MY+White&amp;author=SJ+Cordwell&amp;volume=5&amp;publication_year=2013&amp;pages=20-12&amp;pmid=23445784&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Parker BL, Palmisano G, Edwards AVG, White MY, Engholm-Keller K, Lee A, et al.  Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. <span><span class="ref-journal">Mol Cell Proteomics. </span>2011;<span class="ref-vol">10</span>:M110.006833–M110.006833.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3149091/">PMC free article</a>]</span> [<a href="/pubmed/21441315" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Proteomics&amp;title=Quantitative+N-linked+glycoproteomics+of+myocardial+ischemia+and+reperfusion+injury+reveals+early+remodeling+in+the+extracellular+environment&amp;author=BL+Parker&amp;author=G+Palmisano&amp;author=AVG+Edwards&amp;author=MY+White&amp;author=K+Engholm-Keller&amp;volume=10&amp;publication_year=2011&amp;pages=M110.006833-M110.006833&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Koitabashi N, Kass DA. Reverse remodeling in heart failure--mechanisms and therapeutic opportunities. <span><span class="ref-journal">Nat Rev Cardiol. </span>2012;<span class="ref-vol">9</span>:147–157.</span> [<a href="/pubmed/22143079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cardiol&amp;title=Reverse+remodeling+in+heart+failure--mechanisms+and+therapeutic+opportunities&amp;author=N+Koitabashi&amp;author=DA+Kass&amp;volume=9&amp;publication_year=2012&amp;pages=147-157&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Chakravarti R, Adams JC. Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates. <span><span class="ref-journal">BMC Genomics. </span>2006;<span class="ref-vol">7</span>:83–16.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1464127/">PMC free article</a>]</span> [<a href="/pubmed/16620374" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Genomics&amp;title=Comparative+genomics+of+the+syndecans+defines+an+ancestral+genomic+context+associated+with+matrilins+in+vertebrates&amp;author=R+Chakravarti&amp;author=JC+Adams&amp;volume=7&amp;publication_year=2006&amp;pages=83-16&amp;pmid=16620374&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Finsen AV, Woldbaek PR, Li J, Wu J, Lyberg T, Tønnessen T, et al.  Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling. <span><span class="ref-journal">Physiol Genomics. </span>2004;<span class="ref-vol">16</span>:301–308.</span> [<a href="/pubmed/14625378" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Genomics&amp;title=Increased+syndecan+expression+following+myocardial+infarction+indicates+a+role+in+cardiac+remodeling&amp;author=AV+Finsen&amp;author=PR+Woldbaek&amp;author=J+Li&amp;author=J+Wu&amp;author=T+Lyberg&amp;volume=16&amp;publication_year=2004&amp;pages=301-308&amp;pmid=14625378&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">van Almen GC, Swinnen M, Carai P, Verhesen W, Cleutjens JPM, D’hooge J, et al.  Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. <span><span class="ref-journal">Journal of molecular and cellular cardiology. </span>2011;<span class="ref-vol">51</span>:318–328.</span> [<a href="/pubmed/21624372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+molecular+and+cellular+cardiology&amp;title=Absence+of+thrombospondin-2+increases+cardiomyocyte+damage+and+matrix+disruption+in+doxorubicin-induced+cardiomyopathy&amp;author=GC+van+Almen&amp;author=M+Swinnen&amp;author=P+Carai&amp;author=W+Verhesen&amp;author=JPM+Cleutjens&amp;volume=51&amp;publication_year=2011&amp;pages=318-328&amp;pmid=21624372&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Hu Y-Y, Zheng M-H, Zhang R, Liang Y-M, Han H. Notch signaling pathway and cancer metastasis. <span><span class="ref-journal">Adv Exp Med Biol. </span>2012;<span class="ref-vol">727</span>:186–198.</span> [<a href="/pubmed/22399348" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;title=Notch+signaling+pathway+and+cancer+metastasis&amp;author=Y-Y+Hu&amp;author=M-H+Zheng&amp;author=R+Zhang&amp;author=Y-M+Liang&amp;author=H+Han&amp;volume=727&amp;publication_year=2012&amp;pages=186-198&amp;pmid=22399348&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. <span><span class="ref-journal">Nat Rev Cancer. </span>2008;<span class="ref-vol">8</span>:387–398.</span> [<a href="/pubmed/18432252" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Wnt+signalling+and+its+impact+on+development+and+cancer&amp;author=A+Klaus&amp;author=W+Birchmeier&amp;volume=8&amp;publication_year=2008&amp;pages=387-398&amp;pmid=18432252&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Croquelois A, Domenighetti AA, Nemir M, Lepore M, Rosenblatt-Velin N, Radtke F, et al.  Control of the adaptive response of the heart to stress via the Notch1 receptor pathway. <span><span class="ref-journal">J Exp Med. </span>2008;<span class="ref-vol">205</span>:3173–3185.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2605223/">PMC free article</a>]</span> [<a href="/pubmed/19064701" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Control+of+the+adaptive+response+of+the+heart+to+stress+via+the+Notch1+receptor+pathway&amp;author=A+Croquelois&amp;author=AA+Domenighetti&amp;author=M+Nemir&amp;author=M+Lepore&amp;author=N+Rosenblatt-Velin&amp;volume=205&amp;publication_year=2008&amp;pages=3173-3185&amp;pmid=19064701&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">You J, Wu J, Jiang G, Guo J, Wang S, Li L, et al.  Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. <span><span class="ref-journal">Journal of Cardiovascular Pharmacology. </span>2013;<span class="ref-vol">61</span>:142–151.</span> [<a href="/pubmed/23188126" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Cardiovascular+Pharmacology&amp;title=Olmesartan+attenuates+cardiac+remodeling+through+DLL4/Notch1+pathway+activation+in+pressure+overload+mice&amp;author=J+You&amp;author=J+Wu&amp;author=G+Jiang&amp;author=J+Guo&amp;author=S+Wang&amp;volume=61&amp;publication_year=2013&amp;pages=142-151&amp;pmid=23188126&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Li Y, Hiroi Y, Liao JK. Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. <span><span class="ref-journal">Trends Cardiovasc Med. </span>2010;<span class="ref-vol">20</span>:228–231.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3307142/">PMC free article</a>]</span> [<a href="/pubmed/22293023" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Cardiovasc+Med&amp;title=Notch+signaling+as+an+important+mediator+of+cardiac+repair+and+regeneration+after+myocardial+infarction&amp;author=Y+Li&amp;author=Y+Hiroi&amp;author=JK+Liao&amp;volume=20&amp;publication_year=2010&amp;pages=228-231&amp;pmid=22293023&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS, et al.  Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. <span><span class="ref-journal">Hypertension. </span>2010;<span class="ref-vol">55</span>:939–945.</span> [<a href="/pubmed/20177000" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Wnt+signaling+is+critical+for+maladaptive+cardiac+hypertrophy+and+accelerates+myocardial+remodeling&amp;author=P+Malekar&amp;author=M+Hagenmueller&amp;author=A+Anyanwu&amp;author=S+Buss&amp;author=MR+Streit&amp;volume=55&amp;publication_year=2010&amp;pages=939-945&amp;pmid=20177000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Bergmann MW. WNT Signaling in Adult Cardiac Hypertrophy and Remodeling: Lessons Learned From Cardiac Development. <span><span class="ref-journal">Circulation Research. </span>2010;<span class="ref-vol">107</span>:1198–1208.</span> [<a href="/pubmed/21071717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation+Research&amp;title=WNT+Signaling+in+Adult+Cardiac+Hypertrophy+and+Remodeling:+Lessons+Learned+From+Cardiac+Development&amp;author=MW+Bergmann&amp;volume=107&amp;publication_year=2010&amp;pages=1198-1208&amp;pmid=21071717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Deng S, Wojnowski L. Genotyping the risk of anthracycline-induced cardiotoxicity. <span><span class="ref-journal">Cardiovasc Toxicol. </span>2007;<span class="ref-vol">7</span>:129–134.</span> [<a href="/pubmed/17652817" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc+Toxicol&amp;title=Genotyping+the+risk+of+anthracycline-induced+cardiotoxicity&amp;author=S+Deng&amp;author=L+Wojnowski&amp;volume=7&amp;publication_year=2007&amp;pages=129-134&amp;pmid=17652817&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:306–309.</span> [<a href="/pubmed/11600885" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Replication+validity+of+genetic+association+studies&amp;author=JP+Ioannidis&amp;author=EE+Ntzani&amp;author=TA+Trikalinos&amp;author=DG+Contopoulos-Ioannidis&amp;volume=29&amp;publication_year=2001&amp;pages=306-309&amp;pmid=11600885&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5502740&amp;issue-id=295024&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140527612853152title">Abstract</a></li><li><a href="#S5title">INTRODUCTION</a></li><li><a href="#S6title">METHODS</a></li><li><a href="#S13title">RESULTS</a></li><li><a href="#S17title">DISCUSSION</a></li><li><a href="#S18title">Conclusions</a></li><li><a href="#S19title">Supplementary Material</a></li><li><a href="#S20title">Acknowledgments</a></li><li><a href="#idm140527608170576title">Footnotes</a></li><li><a href="#idm140527615943856title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC5502740/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC5502740/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC5502740/pdf/nihms870773.pdf">PDF (593K)</a></li> | <li><a href="#" data-citationid="PMC5502740" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502740%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502740%2F&amp;text=Genome-wide%20association%20and%20pathway%20analysis%20of%20left%20ventricular%20function%20after%20anthracycline%20exposure%20in%20adults" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502740%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="28542097" data-aiid="5502740" data-aid="5502740" data-iid="295024" data-domainid="319" data-domain="nihpa" data-accid="PMC5502740" data-md5="d97c01971db855bb163dabda94924b1e"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T16:19:01-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8A1441DD5A2FB10000000006B403E5&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502740%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5502740/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>